Allopurinol (Page 5 of 5)
HOW SUPPLIED
Allopurinol Tablets, USP; 100 mg, round, flat, off-white, scored tablet, debossed ‘0524’ over ‘0405’.
Bottles of 100 NDC 55111-729-01
Bottles of 1000 NDC 55111-729-10
300 mg; round, convex, off-white tablet, debossed ‘AL3’.
Bottles of 100 NDC 55111-730-01
Bottles of 500 NDC 55111-730-05
Bottles of 1000 NDC 55111-730-10
Store at 15°-30°C (59°-86°F) and protect from moisture.
QUESTIONS OR COMMENTS? Call toll free 1-888-375-3784.You may report side effects to FDA at 1-800-FDA-1088.
Rx Only
Manufactured by
Dr. Reddy’s Laboratories Louisiana, LLC
Shreveport, LA 71106 USA
Issued August, 2014
150019989-03
Repackaging Information
Please reference the How Supplied section listed above for a description of individual tablets. This drug product has been received by Aphena Pharma — TN in a manufacturer or distributor packaged configuration and repackaged in full compliance with all applicable cGMP regulations. The package configurations available from Aphena are listed below:
Count | 300 mg |
45 | 71610-064-45 |
90 | 71610-064-60 |
Store between 20°-25°C (68°-77°F). See USP Controlled Room Temperature. Dispense in a tight light-resistant container as defined by USP. Keep this and all drugs out of the reach of children.
Repackaged by:
Cookeville, TN 38506
20220422JK
PRINCIPAL DISPLAY PANEL — 300 mg
NDC 71610-064 — Allopurinol 300 mg — Rx Only
ALLOPURINOL allopurinol tablet | ||||||||||||||||||
| ||||||||||||||||||
| ||||||||||||||||||
| ||||||||||||||||||
| ||||||||||||||||||
| ||||||||||||||||||
|
Labeler — Aphena Pharma Solutions — Tennessee, LLC (128385585) |
Establishment | |||
Name | Address | ID/FEI | Operations |
Aphena Pharma Solutions — Tennessee, LLC | 128385585 | REPACK (71610-064) |
Revised: 05/2022 Aphena Pharma Solutions — Tennessee, LLC
All MedLibrary.org resources are included in as near-original form as possible, meaning that the information from the original provider has been rendered here with only typographical or stylistic modifications and not with any substantive alterations of content, meaning or intent.